Category : Search result: IPO listing price


Sudeep Pharma IPO Lists on BSE, NSE Today

Sudeep Pharma makes its stock market debut today. With a GMP of ₹121, the IPO is set for 20% listing gains after a blockbuster 93.72 times subscription. Get all the live details.

Tenneco Clean Air IPO Lists at 27% Premium

Tenneco Clean Air IPO shares made spectacular debut, listing at ₹505 on NSE, 27.2% above issue price. The ₹3,600 crore offer saw massive 61.79x subscription. Read full analysis.

Tenneco Clean Air IPO Lists on BSE, NSE Today

Tenneco Clean Air India shares list today, November 19, 2025. With a strong GMP of ₹103, analysts predict a stellar 26% listing gain. Discover the key financials and subscription details.

PhysicsWallah Shares Jump 49% on Stock Market Debut

PhysicsWallah's stock market debut sees shares surge 33% on NSE. Analysts recommend partial profit booking while holding for long-term growth. Discover the key factors behind this successful IPO.

BillionBrains IPO Jumps 180% on Market Debut

BillionBrains shares surge 180% on NSE/BSE debut after oversubscribed IPO. Get complete details about financial results, investor response, and market outlook for this tech stock.

Emmvee Photovoltaic IPO Lists on BSE, NSE Today

Emmvee Photovoltaic shares list on Indian stock markets today after 97% IPO subscription. Retail investors showed strong interest with 1.10 times subscription. Stay updated on listing performance.

Emmvee Photovoltaic IPO Lists Today on BSE, NSE

Emmvee Photovoltaic IPO listing date is today at 10:00 IST. Learn about share price, GMP trends, financial performance, and expert investment analysis for informed decisions.

PhysicsWallah IPO Lists on BSE, NSE Today

PhysicsWallah shares list on Indian stock exchanges today. GMP signals a 13% premium. Get key details on subscription, price band, and expert analysis.

Emmvee Photovoltaic IPO Flat Listing on November 18

Emmvee Photovoltaic Power IPO concludes with 97% subscription. Shares to list on BSE and NSE on November 18 with estimated flat debut. Complete details on GMP, investor response, and fund utilization.

Page 1 of 4